Caribou Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
29.14
|
|
Average Rating
|
4.71
|
|
# Strong Buys
|
5
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.47
|
0.00
|
0.47
|
100.00%
|
|
2022-12-31
|
-0.47
|
0.00
|
0.47
|
100.00%
|
|
2022-09-30
|
-0.48
|
-0.44
|
0.04
|
8.33%
|
|
2022-06-30
|
-0.36
|
-0.44
|
-0.08
|
-22.22%
|
|
2022-03-31
|
-0.35
|
-0.32
|
0.03
|
8.57%
|
|
2021-12-31
|
-0.36
|
-0.31
|
0.05
|
13.89%
|
|
2021-09-30
|
-0.12
|
-0.46
|
-0.34
|
-283.33%
|
|
2021-06-30
|
0.42
|
-1.55
|
-1.97
|
-469.05%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.20
|
|
2021-12-31
|
-3.25
|
|
2020-12-31
|
-1.39
|
|
2019-12-31
|
-1.16
|